Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





New Solutions for Health Labs Featured at Expo

By Paul Mills, LabMedica Regional Director
Posted on 15 Jul 2013
AACC 2012: High throughput analyzers, clinical information systems, core lab, and cellular analysis systems are being featured in this year's annual AACC/AACLS conference Expo being held July 15-19, 2012, in Los Angeles (CA, USA).

Beckman Coulter (Brea, CA, USA) is displaying its new instruments in a booth configuration—designed to replicate a core lab, reference lab, and regional and community hospital lab. More...
At Beckman Coulter’s in-booth Innovation Station, attendees have the chance learn from industry experts how labs have increased efficiency, productivity, and uptime, and how the latest innovations in in-vitro diagnostics (IVD) testing are advancing patient care. For those unable to attend, live streaming of the event and notification of archived presentations are available online (please see Related Links below).

Also, among the key products being exhibited are the recently released AU5800 chemistry series and Prostate Health Index (phi), which combines the PSA and free PSA with a clipped form of the precursor to PSA, called "-2 pro PSA.”

In addition, Beckman Coulter is sponsoring an industry workshop on July 18, 2012, titled, “Automated and LEAN: Perfect Together, A Decade’s Journey,” which will be led by John T. Mather Memorial Hospital’s (Port Jefferson, NY, USA) Denise Uettwiller-Geiger, PhD, DLM.

Related Links:
Beckman Coulter
Beckman Coulter – Clinical Lab Expo
John T. Mather Memorial Hospital



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
Rapid Molecular Testing Device
FlashDetect Flash10
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.